▁The 3.166015625
▁British 6.66015625
▁bi 8.5
ote 1.380859375
ch 0.37890625
▁firm 1.6884765625
, 2.53125
▁Ac 6.05078125
me 7.21484375
▁Ph 2.92578125
arma 0.01276397705078125
ce 0.305908203125
ut 0.005157470703125
ical 0.0035228729248046875
s 0.0679931640625
, 0.3681640625
▁has 1.0439453125
▁announced 2.001953125
▁that 0.89208984375
▁its 2.0078125
▁new 3.052734375
▁cancer 3.7890625
▁drug 0.58251953125
▁has 2.01953125
▁shown 2.474609375
▁prom 1.875
ising 0.001445770263671875
▁results 0.1817626953125
▁in 0.23876953125
▁early 2.033203125
▁clin 1.4404296875
ical 0.0014400482177734375
▁tri 0.0728759765625
als 0.00013244152069091797
. 0.267822265625
▁However 5.02734375
, 0.03375244140625
▁anal 5.42578125
yst 0.00212860107421875
s 0.01580810546875
▁are 1.3896484375
▁ur 5.3515625
ging 0.0017919540405273438
▁ca 0.275390625
ution 0.00010561943054199219
▁as 2.005859375
▁more 3.77734375
▁testing 3.46875
▁is 0.394775390625
▁needed 0.75927734375
▁to 1.2490234375
▁determine 1.099609375
▁its 2.484375
▁effect 1.408203125
iveness 0.016632080078125
▁and 2.181640625
▁potential 3.28125
▁side 0.30419921875
▁effects 0.1551513671875
. 0.07989501953125
<0x0A> 0.24951171875
The 0.78466796875
▁drug 0.476806640625
, 0.10821533203125
▁named 3.30859375
▁AC 2.09765625
ME 0.66455078125
- 0.386962890625
1 1.2099609375
2 1.72265625
3 0.62744140625
, 0.54296875
▁is 0.4873046875
▁designed 1.01953125
▁to 0.003177642822265625
▁target 0.2025146484375
▁a 0.79736328125
▁specific 0.230712890625
▁protein 0.73876953125
▁found 1.548828125
▁in 0.57080078125
▁certain 2.96875
▁types 0.2386474609375
▁of 0.00015544891357421875
▁cancer 0.055389404296875
▁cells 0.0233917236328125
. 0.28466796875
▁According 3.58203125
▁to 4.029273986816406e-05
▁Ac 0.74267578125
me 5.4955482482910156e-05
▁Ph 0.50537109375
arma 2.6226043701171875e-05
ce 0.010223388671875
ut 3.814697265625e-06
ical 2.1696090698242188e-05
s 0.00262451171875
, 0.035064697265625
▁the 0.425048828125
▁drug 0.146484375
▁has 0.156982421875
▁been 1.826171875
▁successful 3.685546875
▁in 0.01044464111328125
▁in 2.978515625
hib 0.0004420280456542969
iting 0.0002224445343017578
▁the 0.1258544921875
▁growth 0.0809326171875
▁of 0.0992431640625
▁cancer 0.78173828125
▁cells 0.09619140625
▁and 2.767578125
▁indu 3.69140625
cing 0.0009908676147460938
▁cell 2.7890625
▁death 0.0083465576171875
▁in 0.1312255859375
▁labor 2.453125
atory 5.269050598144531e-05
▁tests 1.34375
▁and 3.083984375
▁early 0.720703125
- 3.33984375
stage 0.0321044921875
▁clin 0.15673828125
ical 6.115436553955078e-05
▁tri 0.004608154296875
als 1.0967254638671875e-05
. 0.048309326171875
<0x0A> 0.12548828125
The 1.9794921875
▁tri 5.91796875
als 0.0003528594970703125
▁involved 0.9462890625
▁a 0.413818359375
▁small 0.15087890625
▁group 0.86962890625
▁of 7.402896881103516e-05
▁patients 0.2451171875
▁with 0.1661376953125
▁various 1.255859375
▁types 0.10430908203125
▁of 9.965896606445312e-05
▁cancer 0.08050537109375
, 0.0692138671875
▁including 0.058074951171875
▁lung 1.3935546875
, 0.200439453125
▁breast 0.36767578125
, 0.01218414306640625
▁and 0.0202178955078125
▁colon 1.1591796875
▁cancer 0.143310546875
. 0.035552978515625
▁In 2.94140625
▁these 2.21484375
▁tri 0.14306640625
als 5.9604644775390625e-06
, 8.118152618408203e-05
▁AC 1.529296875
ME 0.0001990795135498047
- 0.0004279613494873047
1 0.00029659271240234375
2 5.996227264404297e-05
3 0.00016629695892333984
▁was 0.5380859375
▁admin 3.71484375
ister 1.633167266845703e-05
ed 3.6954879760742188e-06
▁or 1.2294921875
ally 6.556510925292969e-05
▁in 2.396484375
▁combination 1.7509765625
▁with 0.00017642974853515625
▁other 0.341064453125
▁chem 3.53125
other 0.0007662773132324219
apy 0.0980224609375
▁dru 0.09088134765625
gs 1.1920928955078125e-06
. 0.28857421875
▁The 0.99755859375
▁results 0.4189453125
▁showed 0.443603515625
▁prom 3.375
ising 3.981590270996094e-05
▁redu 3.462890625
ctions 2.086162567138672e-05
▁in 0.0002579689025878906
▁tum 0.2471923828125
or 0.09893798828125
▁size 0.04974365234375
▁and 0.2115478515625
▁improved 1.298828125
▁patient 1.421875
▁out 1.0888671875
comes 5.269050598144531e-05
. 0.52392578125
<0x0A> 0.041259765625
However 0.826171875
, 2.491474151611328e-05
▁anal 2.55078125
yst 0.00017917156219482422
s 0.0008826255798339844
▁warn 2.90234375
▁that 0.00714111328125
▁this 6.515625
▁is 0.8671875
▁just 1.0625
▁the 0.1630859375
▁beginning 0.115234375
▁of 0.3525390625
▁a 2.720703125
▁long 0.12646484375
▁process 1.0576171875
, 3.005859375
▁and 0.216796875
▁it 4.1484375
▁remains 3.138671875
▁unclear 0.97998046875
▁whether 0.416748046875
▁AC 1.6455078125
ME 5.8531761169433594e-05
- 0.0010213851928710938
1 0.0003228187561035156
2 2.849102020263672e-05
3 5.5670738220214844e-05
▁will 0.0904541015625
▁prove 1.9892578125
▁to 0.94580078125
▁be 0.002254486083984375
▁a 2.189453125
▁break 4.1953125
through 3.504753112792969e-05
▁treatment 0.9443359375
▁for 0.55859375
▁cancer 0.0225067138671875
▁or 2.611328125
▁just 1.12109375
▁another 0.1431884765625
▁drug 1.427734375
▁that 0.60302734375
▁doesn 2.73046875
' 1.384765625
t 2.1696090698242188e-05
▁pass 5.47265625
▁the 0.82666015625
▁rig 1.9287109375
orous 0.115966796875
▁testing 0.92919921875
▁process 2.462890625
. 0.22705078125
▁Many 4.8515625
▁dru 1.80078125
gs 3.814697265625e-06
▁that 1.255859375
▁have 0.97802734375
▁shown 0.113037109375
▁promise 1.7177734375
▁in 0.01367950439453125
▁early 0.17431640625
▁tri 0.8349609375
als 1.3232231140136719e-05
▁have 0.1448974609375
▁failed 0.439453125
▁in 1.1259765625
▁larger 1.998046875
, 1.3466796875
▁more 0.41162109375
▁compreh 1.3466796875
ensive 0.00014603137969970703
▁studies 1.1962890625
. 0.221435546875
<0x0A> 0.0650634765625
“ 5.0
Wh 2.1015625
ile 0.0018911361694335938
▁the 0.96240234375
▁early 0.79541015625
▁results 0.2298583984375
▁of 1.9404296875
▁AC 0.779296875
ME 0.0003237724304199219
- 0.0159759521484375
1 0.0003020763397216797
2 0.0001366138458251953
3 0.00012969970703125
▁are 0.0885009765625
▁certainly 3.115234375
▁encourag 0.47900390625
ing 3.814697265625e-06
, 0.013214111328125
▁there 2.935546875
▁is 0.2269287109375
▁still 0.1614990234375
▁a 0.179443359375
▁long 0.336669921875
▁way 0.0662841796875
▁to 0.0005435943603515625
▁go 5.7697296142578125e-05
▁before 0.055084228515625
▁we 0.439697265625
▁can 0.12060546875
▁say 0.806640625
▁whether 2.421875
▁this 0.68701171875
▁drug 0.07733154296875
▁will 0.51318359375
▁be 0.3203125
▁effective 0.92333984375
▁in 0.2529296875
▁tre 0.25341796875
ating 3.933906555175781e-06
▁cancer 0.044586181640625
▁patients 1.5625
,” 0.58935546875
▁said 0.0863037109375
▁Dr 0.1119384765625
. 0.0011262893676757812
▁John 1.9951171875
▁Smith 0.13134765625
, 0.022857666015625
▁an 2.57421875
▁on 0.07696533203125
colog 0.1326904296875
ist 9.250640869140625e-05
▁at 0.1461181640625
▁Harvard 3.76171875
▁Medical 0.11016845703125
▁School 0.051849365234375
. 0.0197906494140625
<0x0A> 1.591796875
Ac 3.294921875
me 0.0008077621459960938
▁Ph 0.00437164306640625
arma 6.61611557006836e-05
ce 0.0015916824340820312
ut 7.62939453125e-06
ical 5.447864532470703e-05
s 0.001861572265625
▁has 1.1611328125
▁stated 1.9794921875
▁that 0.0098876953125
▁it 0.49951171875
▁will 1.5615234375
▁continue 0.06414794921875
▁to 0.08612060546875
▁test 1.7861328125
▁the 1.15625
▁drug 0.01763916015625
▁on 3.298828125
▁a 0.75439453125
▁larger 0.0992431640625
▁group 2.603515625
▁of 0.0017852783203125
▁patients 0.06805419921875
▁in 1.8251953125
▁advanced 6.66015625
- 1.59765625
stage 0.01105499267578125
▁clin 0.1873779296875
ical 7.2479248046875e-05
▁tri 0.00225830078125
als 7.152557373046875e-07
. 0.80859375
▁These 4.48046875
▁tri 0.138916015625
als 4.172325134277344e-06
▁will 0.2496337890625
▁assess 3.462890625
▁the 0.0865478515625
▁drug 0.451904296875
' 0.0716552734375
s 2.0384788513183594e-05
▁safety 1.3408203125
▁and 0.334716796875
▁effect 0.5478515625
iveness 0.00012099742889404297
▁over 2.66796875
▁a 0.1876220703125
▁longer 0.048492431640625
▁period 0.0224609375
▁of 0.8681640625
▁time 0.003513336181640625
▁and 1.2412109375
▁in 0.634765625
▁a 0.66162109375
▁more 0.7353515625
▁diverse 0.4462890625
▁group 1.18359375
▁of 0.00075531005859375
▁patients 0.251953125
. 0.05810546875
<0x0A> 0.1343994140625
The 1.5322265625
▁success 4.9296875
▁of 0.0242462158203125
▁AC 0.2197265625
ME 9.644031524658203e-05
- 0.0011377334594726562
1 0.0001882314682006836
2 4.649162292480469e-05
3 8.034706115722656e-05
▁is 2.095703125
▁of 6.29296875
▁great 0.94482421875
▁importance 1.3642578125
▁to 0.54541015625
▁the 0.310791015625
▁bi 1.158203125
ote 0.0419921875
ch 0.07427978515625
▁industry 0.0711669921875
, 0.461181640625
▁which 0.468017578125
▁has 0.317626953125
▁been 0.501953125
▁struggling 0.92626953125
▁to 0.55224609375
▁develop 0.5029296875
▁effective 1.697265625
▁cancer 1.404296875
▁dru 1.4921875
gs 5.960464477539062e-07
. 1.578125
▁Can 2.642578125
cer 0.0003352165222167969
▁remains 1.87890625
▁one 0.287353515625
▁of 9.107589721679688e-05
▁the 0.0023288726806640625
▁leading 0.06304931640625
▁causes 0.0012989044189453125
▁of 2.086162567138672e-05
▁death 0.0027637481689453125
▁world 0.398193359375
wide 2.968311309814453e-05
, 0.0122222900390625
▁with 1.4638671875
▁over 1.5048828125
▁ 0.021087646484375
9 1.095703125
. 1.20703125
6 0.334228515625
▁million 0.0006670951843261719
▁death 0.6142578125
s 1.3709068298339844e-05
▁reported 1.3193359375
▁in 0.04345703125
▁ 0.0007534027099609375
2 2.86102294921875e-05
0 5.364418029785156e-05
1 0.451171875
8 0.02178955078125
. 0.77880859375
<0x0A> 0.935546875
More 5.29296875
over 1.3955078125
, 0.0001914501190185547
▁cancer 2.501953125
▁dru 1.8154296875
gs 2.384185791015625e-07
▁are 1.072265625
▁not 2.189453125
or 0.377197265625
iously 2.0742416381835938e-05
▁difficult 3.68359375
▁to 0.01129913330078125
▁develop 0.01482391357421875
▁as 4.68359375
▁they 0.11309814453125
▁must 1.2431640625
▁target 1.6884765625
▁cancer 3.77734375
▁cells 0.0274658203125
▁without 0.908203125
▁harm 0.65185546875
ing 6.16312026977539e-05
▁health 0.060302734375
y 2.9921531677246094e-05
▁ones 1.9873046875
. 0.103271484375
▁Many 2.236328125
▁dru 0.59619140625
gs 8.344650268554688e-07
▁that 0.4287109375
▁show 2.24609375
▁promise 0.2451171875
▁in 0.0156707763671875
▁early 0.09027099609375
▁tri 0.271240234375
als 1.0967254638671875e-05
▁do 4.203125
▁not 0.001392364501953125
▁make 0.74169921875
▁it 0.0017595291137695312
▁to 0.759765625
▁the 1.3017578125
▁market 0.0335693359375
▁due 0.19677734375
▁to 4.5299530029296875e-05
▁un 3.125
for 0.1337890625
ese 4.017353057861328e-05
en 0.0006785392761230469
▁side 0.07330322265625
▁effects 0.0003783702850341797
. 3.166015625
<0x0A> 0.0882568359375
Ac 1.9189453125
me 0.00048828125
▁Ph 0.0037212371826171875
arma 1.9311904907226562e-05
ce 0.00036597251892089844
ut 4.291534423828125e-06
ical 2.562999725341797e-05
s 0.0017871856689453125
▁is 1.2421875
▁not 1.3837890625
▁the 0.110107421875
▁only 0.0814208984375
▁company 0.2349853515625
▁developing 2.4296875
▁cancer 0.61474609375
▁dru 0.048675537109375
gs 5.960464477539062e-07
. 0.1483154296875
▁In 4.4609375
▁fact 1.0185546875
, 0.00012576580047607422
▁the 0.9814453125
▁field 2.80078125
▁is 0.193359375
▁highly 1.6240234375
▁compet 0.0034084320068359375
itive 1.1444091796875e-05
▁and 3.658203125
▁there 3.017578125
▁are 0.0142059326171875
▁many 0.473876953125
▁other 0.64892578125
▁fir 2.94140625
ms 7.748603820800781e-06
▁working 0.71337890625
▁on 0.11724853515625
▁similar 0.634765625
▁treat 1.13671875
ments 1.0371208190917969e-05
. 0.01047515869140625
▁However 1.6943359375
, 3.814697265625e-05
▁the 0.70947265625
▁success 0.990234375
▁of 0.0013093948364257812
▁AC 0.036651611328125
ME 5.2094459533691406e-05
- 0.0005869865417480469
1 0.00036835670471191406
2 8.666515350341797e-05
3 9.703636169433594e-05
▁could 0.62744140625
▁be 2.31640625
▁a 0.039306640625
▁significant 1.640625
▁break 0.57666015625
through 4.5180320739746094e-05
▁in 0.444580078125
▁the 0.048858642578125
▁fight 0.2783203125
▁against 6.580352783203125e-05
▁cancer 0.0105438232421875
. 0.6015625
<0x0A> 0.0902099609375
Des 3.4453125
p 0.00092315673828125
ite 0.0001226663589477539
▁this 3.40234375
, 0.70947265625
▁anal 1.2646484375
yst 6.139278411865234e-05
s 0.0004715919494628906
▁ca 2.1953125
ution 0.0005059242248535156
▁against 1.7080078125
▁becoming 4.96484375
▁too 0.70556640625
▁optim 0.208740234375
istic 3.7550926208496094e-05
▁about 0.97119140625
▁the 0.1517333984375
▁drug 0.2271728515625
' 0.1949462890625
s 1.0967254638671875e-05
▁potential 0.2218017578125
. 0.253662109375
▁There 2.650390625
▁is 0.77734375
▁still 0.322021484375
▁a 0.330322265625
▁great 5.5546875
▁deal 0.005767822265625
▁of 0.005580902099609375
▁work 1.1416015625
▁to 0.2255859375
▁be 0.00965118408203125
▁done 4.00543212890625e-05
▁before 0.441650390625
▁AC 0.990234375
ME 0.00021266937255859375
- 0.0007872581481933594
1 0.0002810955047607422
2 0.00012552738189697266
3 0.00013446807861328125
▁can 0.1683349609375
▁be 0.07861328125
▁approved 1.2890625
▁for 0.08740234375
▁use 0.39697265625
▁by 2.09375
▁patients 1.7607421875
. 0.1519775390625
<0x0A> 0.8212890625
“ 1.279296875
Wh 1.3798828125
ile 0.00010097026824951172
▁we 1.8671875
▁are 0.1673583984375
▁excited 2.1015625
▁by 0.57763671875
▁the 0.07171630859375
▁early 0.1785888671875
▁results 0.032379150390625
, 1.962890625
▁it 1.6298828125
▁is 0.25732421875
▁important 0.20556640625
▁to 0.0401611328125
▁remember 0.140625
▁that 0.0002732276916503906
▁developing 7.61328125
▁cancer 2.16015625
▁dru 0.08660888671875
gs 7.152557373046875e-07
▁is 0.037750244140625
▁a 0.07855224609375
▁long 0.311767578125
▁journey 8.390625
, 2.2578125
▁and 0.228271484375
▁many 2.68359375
▁challeng 4.58203125
es 0.00029158592224121094
▁still 1.923828125
▁need 2.783203125
▁to 3.814697265625e-05
▁be 1.5616416931152344e-05
▁overcome 0.26611328125
,” 0.40576171875
▁said 0.051300048828125
▁Beck 12.375
y 0.0168914794921875
▁Jones 1.3623046875
, 0.004486083984375
▁an 1.705078125
▁anal 0.1324462890625
yst 4.76837158203125e-06
▁at 0.027862548828125
▁Morgan 1.5380859375
▁Stanley 0.00514984130859375
. 0.007137298583984375
<0x0A> 0.2369384765625
The 1.98828125
▁next 2.765625
▁phases 8.140625
▁of 0.0015468597412109375
▁clin 0.7431640625
ical 1.823902130126953e-05
▁tri 0.03192138671875
als 3.0994415283203125e-06
▁for 0.96630859375
▁AC 0.0253143310546875
ME 0.00010538101196289062
- 0.0006833076477050781
1 0.0003151893615722656
2 0.00011479854583740234
3 0.00012886524200439453
▁are 1.6171875
▁expected 0.404296875
▁to 0.0003399848937988281
▁take 1.6865234375
▁several 0.8857421875
▁years 0.00832366943359375
▁to 1.1962890625
▁complete 0.0030651092529296875
. 0.315673828125
▁Only 4.390625
▁then 0.56982421875
▁will 0.1556396484375
▁we 0.810546875
▁have 2.216796875
▁a 0.0258026123046875
▁better 1.240234375
▁idea 1.63671875
▁of 0.003223419189453125
▁whether 0.315185546875
▁this 0.6259765625
▁drug 0.1322021484375
▁can 1.3544921875
▁provide 3.572265625
▁real 3.912109375
▁hope 1.4892578125
▁for 0.29248046875
▁cancer 0.17431640625
▁patients 0.0007925033569335938
. 0.465087890625
▁For 5.9375
▁now 0.016998291015625
, 9.21487808227539e-05
▁the 1.833984375
▁industry 4.1484375
▁is 1.5107421875
▁watching 1.1796875
▁closely 0.417236328125
▁and 2.693359375
▁c 4.54296875
aut 2.8371810913085938e-05
iously 0.00412750244140625
▁optim 0.52880859375
istic 0.00010120868682861328
▁about 0.50927734375
▁what 2.650390625
▁the 0.268310546875
▁future 0.017608642578125
▁holds 1.1181640625
. 0.3037109375
